Abstract:Based on more than 100 references, the present paper reviews the progress in the application of nuclear magnetic resonance (NMR) spectroscopy, an effective method to study the variation in chemical composition and molecular structure in biological samples for early diagnosis of cancer at molecular level. In the past several decades, numerous works have demonstrated that NMR spectroscopy may be developed into a sensitive diagnosis method to detect cancer in early stage. Because of the rapid development of NMR spectroscopic techniques, it becomes possible to record NMR spectra of biological samples in both in-vitro and in-vivo manner. Systematic spectral differences between biological samples from cancer patients and normal controls can be observed from both liquid-state and solid-state 1H, 31P NMR spectra and used to reflect the changes in metabolic behavior of malignant tissues. This paper has summarized NMR spectroscopic investigation on biological fluid, cultured cancerous cells, resected tissues, as well as in-vivo malignant tissues by using various advanced NMR techniques including recently developedhigh-resolution magic angle spinning (HR-MAS)and magnetic resonance spectroscopy and imaging (MRSI) methods. First, characteristic peaks, which are related to choline, phosphocholine (PC) and glycerophosphocholine, can be observed in both 1H and 31P NMR spectra of biological fluid samples from cancer patients. These results indicate that alternation in the metabolic pattern occurs with the progression of cancer. The research on cultured cells by using NMR spectroscopy showed that the signal of various phospholipids and their metabolites such as PME increased significantly in cultured cancer cells. For resected tissues, two methods can be utilized. The first one is to investigate the tissues directly by using HR-MAS spectroscopy. The second method is to extract various metabolites with various solvents such as CHCl3/methonal mixtures, HClO4 solutions, etc. and then analysis of the extracted solutions is performed using conventional liquid NMR spectroscopy. Significant differences on the content of various amino acids, metabolites of phospholipids, can be observed between malignant tissues and normal controls in NMR spectra. Recently, MRSI that can acquire 1H-NMR spectra of suspected tissues during the process of MRI diagnosis is available. The approach makes it possible for the surgeons to judge whether the suspected tissues are malignant or not before surgical operation. The above results demonstrate that NMR spectroscopy possesses bright perspective in diagnosing cancers and differentiating different types of cancers based on the metabolic behavior of cancerous tissues.

1H-MR Spectroscopy of Bone and Soft Tissue Tumors with in Vivo

Study Of Single Voxel H-1 Mr Spectroscopy Of Bone Tumors: Differentiation Of Benign From Malignant Tumors

Hydrogen Magnetic Resonance Spectroscopy in the Diagnosis of Musculoskeletal System Tumors

The Value of Magnetic Resonance Spectroscopy (1H-MRS) in the Soft Tissue Tumors of the Extremities

Primary Investigation of the Value of Multi-Voxel 1H-MRS in Differential Diagnosis of Benign and Malignant Musculoskeletal Lesions of Limbs

In Vivo Hydrogen-1 Magnetic Resonance Spectroscopy Study of Human Intracranial Tumors.

In Vitro Brain Tumors: Initial Study Using High Resolution Magic Angle Spinning 1H MR Spectroscopy

Magnetic Resonance Spectroscopy in Differential Diagnosis of Brain Tumor

In vivo MR spectroscopy for breast cancer diagnosis

Initial Application of in vivo Proton MR Spectroscopy on Hepatic Neoplasm on 3.0T

Comparison of MR Spectroscopic Characteristics Between Orbital Tumor and Normal Tissues in Vitro by Super High Field MR

Preliminary Study of Proton MR Spectroscopy in Distinguishing Benign from Malignant Intracranial Lesions and Predicting the Malignancy of Tumors

Differential diagnosis in the intracranial diseases: Proton magnetic resonance spectroscopy study

Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy

Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.

[Progress in Nuclear Magnetic Resonance Spectroscopy for Early Cancer Diagnosis].

Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T

Diagnostic value of 3.0T 1H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors

Value of 1H-MRS in the Diagnosis of Breast Lesions

Study of 3D-magnetic resonance spectroscopy imaging in prostate cancer and benign prostate hyperplasia

Study of Magnetic Resonance Spectroscopy of Comnon Intracranial Tumors